|
propGroup.PropGroupId
|
|
2
|
Name
|
|
6
|
Birth Date
|
|
3
|
Age
|
|
4
|
Gender
|
|
57
|
Residency
|
|
60
|
Occupation
|
|
8
|
Weight (kg)
|
|
7
|
Height (m)
|
|
59
|
BMI (Body Mass Index)
|
|
16
|
Smoking
|
|
2096
|
Informed Consent
|
|
1
|
|
|
|
propGroup.PropGroupId
|
|
2086
|
Diseases (MTX Applied for)
|
|
228
|
Dose
|
|
2285
|
Administration
|
|
2089
|
Duration of treatment
|
|
2088
|
Interval between treatment doses
|
|
2100
|
Response
|
|
2101
|
Patient Compliance
|
|
2102
|
Adherence to MTX
|
|
2
|
|
|
|
propGroup.PropGroupId
|
|
2284
|
GIT Upset
|
|
2103
|
Bone Marrow suppression
|
|
2104
|
Elevated Liver Enzymes (ALT& AST)
|
|
2105
|
Pneumonitis
|
|
2107
|
Teratogenicity
|
|
2108
|
Stomatitis
|
|
2109
|
MTX Nodulosis
|
|
2110
|
Megaloblastic Anemia
|
|
3
|
|
|
|
propGroup.PropGroupId
|
|
2092
|
Primary failure
|
|
2111
|
Switched to (after primary failure)
|
|
2094
|
Secondary failure
|
|
2112
|
Switched to (after secondary failure)
|
|
4
|
|
|